Citation 71026

BRUNO,I: MINALE,L: RICCIO,R: CARIELLO,L: HIGA,T: TANAKA,J:. (1993). STARFISH SAPONINS, PART 50. STEROIDAL GLYCOSIDES FROM THE OKINAWAN STARFISH NARDOA TUBERCULATA.. 56(7)

Citation Details

TitleSTARFISH SAPONINS, PART 50. STEROIDAL GLYCOSIDES FROM THE OKINAWAN STARFISH NARDOA TUBERCULATA.
AuthorsBRUNO,I: MINALE,L: RICCIO,R: CARIELLO,L: HIGA,T: TANAKA,J:
Year1993
Volume56
Issue7

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Nardoa tubercolata (LINCKIIDAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
HALITYLOSIDE A
None
2
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
HALITYLOSIDE A
WEAK ACTIVITY
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HALITYLOSIDE A
ACTIVE
4Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
HALITYLOSIDE B
None
5Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CULCITOSIDE C-1
None
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HALITYLOSIDE B
ACTIVE
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CULCITOSIDE C-1
ACTIVE
8Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
HALITYLOSIDE E
None
9Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
HALITYLOSIDE F
None
10
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
HALITYLOSIDE E
ACTIVE
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HALITYLOSIDE E
ACTIVE
12
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
HALITYLOSIDE F
ACTIVE
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HALITYLOSIDE F
ACTIVE
14Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HALITYLOSIDE A 6-O-SULFATE
None
15Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HALITYLOSIDE A,4''-O-METHYL: 6-O-SULFATE
None
16Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HALITYLOSIDE A,22-DEHYDRO: 4''-O-METHYL: 6-O-SULFATE
None
17Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CULCITOSIDE C-7,22-DEHYDRO:
None
18Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLESTANE-3-BETA-6-ALPHA-8-15-BETA-24(S)-PENTAOL,5-ALPHA:
None
19Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLESTANE-3-BETA-4-BETA-6-ALPHA-8-15-BETA-24(S)-HEXOL,5-ALPHA:
None
20
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHOLESTANE-3-BETA-6-ALPHA-8-15-BETA-24(S)-PENTAOL,5-ALPHA:
ACTIVE
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTANE-3-BETA-6-ALPHA-8-15-BETA-24(S)-PENTAOL,5-ALPHA:
INACTIVE
22
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTANE-3-BETA-4-BETA-6-ALPHA-8-15-BETA-24(S)-HEXOL,5-ALPHA:
ACTIVE
Show SPARQL Queries (1)